Gerben DeJong, PhD, FACRM is a Senior Fellow for Health Policy & Post-acute Care at the MedStar National Rehabilitation Hospital (NRH). Dr. DeJong serves as Professor in the Department ofRehabilitation Medicine at the Georgetown University School of Medicine in Washington, DC. He is also a Senior Partner with DeltaMed Partners, LLC, a health facility development and analysis firm based in Naples, FL and doing work in emerging health care markets in Asia.
Prior to rejoining MedStar NRH in late 2004, Dr. DeJong served a 2-year stint with the University of Florida as a professor in the Department of Health Services Research, Management & Policy. Previously until 2001, Dr. DeJong served for 16 years (1985-2001) as MedStar NRH’s founding Director of Research.
Dr. DeJong has conducted several large multi-center clinical and health outcome studies. He is the author or co-author of more than 250 papers on health policy, health care financing, post-acute care, and health outcomes. For more than 30 years, Dr. DeJong has tracked American post-acute health care system and its publicly traded companies, especially their growth, development, and consolidation. He is also an avid student of health care reform and has lectured widely on the topic.
In 2006-07, Dr. DeJong served as President of the American Congress of Rehabilitation Medicine. He is the recipient of many awards and is a frequently invited speaker both in the United States and abroad. In 1984, he was a Fulbright Scholar in the Netherlands. In 2013, Dr. DeJong was the William Evans Visiting Fellow with the Department of Orthopaedic Surgery & Musculoskeletal Medicine at University of Otago and the Burwood Academy in Christchurch, New Zealand.
Dr. DeJong received his PhD in public policy studies from Brandeis University in 1980.
Dr. DeJong's areas of research include
- Health policy and healthcare reform, including value-based purchasing and accountable care organizations
- Income maintenance
- Post-acute care and rehabilitation
- Health outcomes
Dr. DeJong is a member of the MedStar Health Research Institute Board of Directors and MHRI's Scientific Advisory Board, and he serves as the Chair of MedStar's Health Services Research Working Group.